Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Analysis of entities with the lowest risk in crypto, plus how to interpret liquidity, use case maturity, and developer activity for safer bets.
28,397 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
A steady-income approach from JEPI tests traditional retirement cash flow models as market volatility shapes option p...
As investors seek simplicity and liquidity in a volatile rate environment, the PIMCO Enhanced Short Maturity Active E...
Brady Corporation has captured market attention with a rapid rally. Learn what’s driving shares brady corporation soa...
Planet Fitness posted a robust surge in revenue, but a large investor trimmed a substantial stake. This article break...
This in-depth guide breaks down what to watch in Ziff Davis's Q1 2026 earnings transcript, how growth drivers shape t...
A Perdoceo director recently exercised 9,308 options and sold shares, triggering questions for investors. This guide ...
Oil prices are falling, delivering relief to some budgets, but the Fed's decision to hold rates could keep mortgage c...
The next decade could test Detroit's big automakers as profits shift from rugged trucks to electric and software-led ...
As America reshapes its manufacturing landscape, rare earths play a pivotal role in magnets, EVs, and wind turbines. ...
Alphabet’s cloud momentum is reshaping the risk-and-reward profile for investors. This article explains why the googl...
Amazon's latest update from AWS leadership sparked a fresh investor conversation. This article breaks down what happe...